198 related articles for article (PubMed ID: 34870681)
1. Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.
Rance G; Zanin J; Maier A; Chisari D; Haebich KM; North KN; Dabscheck G; Seal ML; Delatycki MB; Payne JM
JAMA Netw Open; 2021 Dec; 4(12):e2136842. PubMed ID: 34870681
[TBL] [Abstract][Full Text] [Related]
2. Auditory temporal processing deficits and language disorders in patients with neurofibromatosis type 1.
Batista PB; Lemos SM; Rodrigues LO; de Rezende NA
J Commun Disord; 2014; 48():18-26. PubMed ID: 24447521
[TBL] [Abstract][Full Text] [Related]
3. Amusia and its electrophysiological correlates in neurofibromatosis type 1.
Cota BCL; Fonseca JGM; Rodrigues LOC; Rezende NA; Batista PB; Riccardi VM; Resende LM
Arq Neuropsiquiatr; 2018 May; 76(5):287-295. PubMed ID: 29898074
[TBL] [Abstract][Full Text] [Related]
4. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
[TBL] [Abstract][Full Text] [Related]
5. Hearing with Two Ears: Evidence for Cortical Binaural Interaction during Auditory Processing.
Henkin Y; Yaar-Soffer Y; Givon L; Hildesheimer M
J Am Acad Audiol; 2015 Apr; 26(4):384-92. PubMed ID: 25879242
[TBL] [Abstract][Full Text] [Related]
6. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological findings in neurofibromatosis type 1.
Yerdelen D; Koc F; Durdu M; Karakas M
J Neurol Sci; 2011 Jul; 306(1-2):42-8. PubMed ID: 21501851
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.
Rance G; Maier A; Zanin J; Haebich KM; North KN; Orsini F; Dabscheck G; Delatycki MB; Payne JM
Neurol Sci; 2022 Sep; 43(9):5637-5641. PubMed ID: 35723774
[TBL] [Abstract][Full Text] [Related]
10. Pediatric audiologic profile in type 1 and type 2 neurofibromatosis.
Pikus AT
J Am Acad Audiol; 1995 Jan; 6(1):54-62. PubMed ID: 7696678
[TBL] [Abstract][Full Text] [Related]
11. Auditory neuropathy: endocochlear lesion or temporal processing impairment? Implications for diagnosis and management.
Vlastarakos PV; Nikolopoulos TP; Tavoulari E; Papacharalambous G; Korres S
Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1135-50. PubMed ID: 18502518
[TBL] [Abstract][Full Text] [Related]
12. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Auditory Pathways Using Diffusion Tensor Imaging in Patients with Neurofibromatosis Type 1.
Meydan S; Aydin S; Otcu H; Kitis S; Alkan A
Curr Med Imaging Rev; 2019; 15(9):890-894. PubMed ID: 32008535
[TBL] [Abstract][Full Text] [Related]
14. Fiber-Specific Changes in White Matter Microstructure in Individuals With X-Linked Auditory Neuropathy.
Zanin J; Dhollander T; Rance G; Yu L; Lan L; Wang H; Lou X; Connelly A; Nayagam B; Wang Q
Ear Hear; 2020; 41(6):1703-1714. PubMed ID: 33136644
[TBL] [Abstract][Full Text] [Related]
15. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
16. Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas.
Idowu V; Christensen J; Gross AM; Dombi E; Miles JR; King K; Chisholm J; Zalewski C; Baldwin A; Whitcomb P; Burgess C; Widemann BC; Brewer CC; Kim HJ
Laryngoscope; 2023 Oct; 133(10):2770-2778. PubMed ID: 36583617
[TBL] [Abstract][Full Text] [Related]
17. Benefits of intervention in the Central Auditory Nervous System in individuals with Neurofibromatosis Type 1.
Fontanelli RCFL; Aragão MM; Pinho RS; Gil D
Int J Pediatr Otorhinolaryngol; 2023 Sep; 172():111692. PubMed ID: 37542812
[TBL] [Abstract][Full Text] [Related]
18. Impaired engagement of the ventral attention system in neurofibromatosis type 1.
Pride NA; Korgaonkar MS; North KN; Payne JM
Brain Imaging Behav; 2018 Apr; 12(2):499-508. PubMed ID: 28364401
[TBL] [Abstract][Full Text] [Related]
19. Cognitive control in adolescents with neurofibromatosis type 1.
Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
[TBL] [Abstract][Full Text] [Related]
20. Mild-Gain Hearing Aids as a Treatment for Adults with Self-Reported Hearing Difficulties.
Roup CM; Post E; Lewis J
J Am Acad Audiol; 2018 Jun; 29(6):477-494. PubMed ID: 29863462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
